<DOC>
	<DOCNO>NCT02360631</DOCNO>
	<brief_summary>The purpose study examine whether provide Chantix ( varenicline ) help African American smoker quit smoking .</brief_summary>
	<brief_title>Advancing Tobacco Use Treatment African American Smokers</brief_title>
	<detailed_description>To impact premature mortality African American smoker , effective treatment smoker across smoke continuum must identify . Varenicline , lead first-line medication tobacco use treatment , triple likelihood long-term abstinence relative placebo smoking &gt; 10 cpd . To date , efficacy varenicline establish African American smoker light smoker . The long-term goal research advance treatment African American smoker order reduce tobacco-related disease death . Our primary objective evaluate efficacy varenicline tobacco use treatment among 500 African American smoker , include full range cpd , within double-blind , placebo-controlled , randomized clinical trial . We randomize participant 3:2 ratio receive varenicline ( 1 mg bid ; n=300 ) placebo ( n=200 ) 12 week , along individualized health education counsel participant . Our specific aim evaluate efficacy varenicline promote abstinence African American smoker across continuum smoking level , examine efficacy light smoker also moderate heavy smoker , characterize nicotine carcinogen exposure , describe biopsychosocial characteristic group evaluate relation abstinence . This innovative study provide first placebo-controlled evaluation varenicline full spectrum African American smoker , first examine varenicline light smoker . Findings contribute advance effective treatment African American smoker light smoker , enhance individualized treatment . Increased treatment efficacy major impact reduce tobacco-related morbidity mortality high-risk population .</detailed_description>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Selfidentified African American Smokes ≥ 1 cigarette per day ( cpd ) Smoke ≥ 25 day past 30 day Functioning telephone Interested quit smoking Interested take 3 month varenicline Willing complete study visit Renal impairment Evidence history clinically significant allergic reaction varenicline A cardiovascular event past month History alcohol drug dependence past year Major depressive disorder last year require treatment History panic disorder , psychosis , bipolar disorder , eat disorder Use tobacco product cigarettes past 30 day Use pharmacotherapy month prior enrollment , include prior use varenicline Pregnant , contemplate get pregnant , breastfeed Plans move Kansas City treatment followup phase Another household member enrol study Evidence current severe major depressive disorder suicidal ideation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>smoking</keyword>
	<keyword>quit smoking</keyword>
	<keyword>smoking treatment</keyword>
</DOC>